Back to Rathbones Group PLC Rathbones Group PLC

ORMPORMP
12 quarters

Position history for Rathbones Group PLCRathbones Group PLC's holdings in ORAMED PHARMACEUTICALS INC

Rathbones Group PLC holds 233,018 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $1.1M as of 2026-Q2. The position was decreased (-50.0% shares). ORMP represents 0.0% of Rathbones Group PLC's portfolio.

Current Value

$1.1M

Current Shares

233,018

Total Value Change

+$364,430

Total Shares Change

-56,785

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
233,018
-50.0%
$1.1M0.0%$4.81
0
2026-Q1
Unchanged
466,036
0.0%
$1.6M0.0%$3.38
0
2025-Q4
Increased
466,036
+100.0%
$1.3M0.0%$2.62
41
2025-Q3
Unchanged
233,018
0.0%
$615,1670.0%$2.52
0
2025-Q2
Decreased
233,018
-1.6%
$524,2900.0%$2.00
0
2025-Q1
Decreased
236,803
-18.3%
$506,7580.0%$2.06
0
2024-Q4
Unchanged
289,803
0.0%
$701,3230.0%$2.17
0
2024-Q3
Unchanged
289,803
0.0%
$707,1190.0%$2.31
0
2024-Q2
Unchanged
289,803
0.0%
$744,7940.0%$2.40
0
2024-Q1
Unchanged
289,803
0.0%
$846,2250.0%$2.72
0
2023-Q4
Unchanged
289,803
0.0%
$669,4450.0%$2.15
0
2023-Q3
New
289,803
-
$756,3860.0%$2.43
34

Other major holders of ORMP: Steward Partners Investment Advisory, LLC, BNP PARIBAS FINANCIAL MARKETS, MERCER GLOBAL ADVISORS INC /ADV, Invesco Ltd., MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used